Ocular Genomics
243 Charles Street Boston, MA 02114 Contact us
Diagnostic Testing
Support our research
Explore our labs
Ocular Genomics MENU
Ocular Genomics
  • Meet the Team
  • Services
    • Biobank Core Services
    • Bioinformatics and Statistics Core
    • Functional Genomics (Zebrafish) Core
    • Gene Transfer Vector
      • Rates
      • Order Information
      • Contact Us
    • Genetic Diagnostic Testing Service
      • Pricing
    • Genomics Core Services
      • Sample Processing
      • Sequencing
      • Other Genomics Services
    • IRD service
  • Labs
    • Amamoto lab
      • Lab Members
    • Biobank Core
    • Bujakowska Lab
      • Lab Members
      • Publications
    • Comander Lab
      • Lab Members
      • Publications
    • Engle Lab
    • Functional Genomics Core (Zebrafish Facility)
      • Lab Members
    • Genetic Counseling Team
      • Team Members
    • Genomics Core Lab
      • Lab Members
    • iPS Research Lab
      • Lab Members
      • Grant support
      • Publications
    • Liu Lab
      • Lab Members
      • Publications
      • Projects
    • Mary Whitman Lab
      • Lab Members
    • MEEI Bioinformatics Center (MBC)
      • Lab Members
    • Pierce Lab
      • Lab Members
      • Publications
      • Projects
    • Segrè Lab
      • Selected Publications
    • Vandenberghe Lab
      • Lab Members
    • Wiggs Lab
      • Lab Members
  • News & Publications
    • RETINAL Transcriptome
  • Affiliates
  • Careers
  • Home
  • Labs
  • Liu Lab
  • Projects
  • Genome editing for dominant IRDs

LABS

  • Amamoto lab
    • Lab Members
  • Biobank Core
  • Bujakowska Lab
    • Lab Members
    • Publications
  • Comander Lab
    • Lab Members
    • Publications
  • Engle Lab
    • Publications
  • Functional Genomics Core (Zebrafish Facility)
    • Lab Members
  • Genetic Counseling Team
    • Team Members
  • Genomics Core Lab
    • Lab Members
  • iPS Research Lab
    • Grant support
    • Lab Members
    • Publications
  • Liu Lab
    • Lab Members
    • Publications
    • Projects
      • Retinitis Pigmentosa 1
      • Genome editing for dominant IRDs
      • Genome editing for USH2A associated IRD
  • MEEI Bioinformatics Center (MBC)
    • Lab Members
  • Pierce Lab
    • Lab Members
    • Publications
    • Projects
      • Retinal Degeneration Disease Gene Discovery
      • NMNAT1 Leber Congenital Amaurosis (LCA)
      • Novel Photoreceptor Sensory Cilia Proteins
      • RNA Splicing Factor Retinitis Pigmentosa/Transcriptome Analyses
      • Pericentral Retinitis Pigmentosa
      • High-throughput Functional Studies of Sequence Variants
  • Segrè Lab
    • Selected Publications
    • Lab Members
  • Vandenberghe Lab
    • Lab Members
  • Whitman Lab
    • Lab Members
  • Wiggs Lab
    • Inas Aboobakar
    • Lab Members

Inherited retinal diseases (IRDs) are a large group of clinically and genetically heterogeneous disorders, the most common cause of severe vision loss, ultimately leading to blindness, affecting approximately 1 in 3000 people worldwide. IRDs may be restricted to the retina (such as retinitis pigmentosa, cone-rod dystrophy, Usher syndrome, and Bardet-Bidel syndrome) or the macular (e.g., Stargardt disease, Best disease, and Sorsby fundus dystrophy). The majority of IRDs may be inherited as autosomal dominant, autosomal recessive, and X-linked traits.

Although numerous attempts to cure IRDs has been made in the past two decades, such as gene augment therapy for treating autosomal recessive IRDs, currently there are no effective treatments available for IRDs, especially the autosomal dominant IRDs, in which the dominant mutations need to be inactivated or ablated. Toward this goal, we are developing a therapeutic approach by utilizing the most commonly used CRISPR/Cas9-mediated genome editing system to specifically disrupt the mutant alleles associated with autosomal dominant IRDs, therefore to prevent the retinal degenerations to improve IRDs patients’ life quality.